Durability of culture conversion in patients receiving Amikacin Liposome Inhalation Suspension (ALIS) for treatment-refractory Mycobacterium avium complex lung disease (MAC-LD) in the CONVERT study
Proceedings article published in 2019 by
David E. Griffith,
Rachel Thomson,
Doreen J. Addrizzo-Harris,
Stephen K. Field,
Jakko Van Ingen,
Christopher Coulter,
Kevin Mange,
James Nezamis,
Kevin L. Winthrop
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 